Traynor Capital Management, Inc. Immunity Bio, Inc. Call Options Transaction History

Traynor Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 24, 2024	BUY	$3.32 - $6.7 $22,576 - $45,560	6,800 Added 70.83%	16,400 $60,000
Q2 2024 Jul 24, 2024	BUY	$4.82 - $9.15 $26,992 - $51,240	5,600 Added 140.0%	9,600 $60,000
Q1 2024 Apr 12, 2024	BUY	$3.23 - $6.17 $3,230 - $6,170	1,000 Added 33.33%	4,000 $21,000
Q4 2023 Jan 18, 2024	BUY	$1.25 - $5.21 $3,750 - $15,630	3,000 New	3,000 $15,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.